← Browse by Condition
Medical Condition

deep brain stimulation

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for deep brain stimulation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — deep brain stimulation Clinical Trials

How many clinical trials are currently recruiting for deep brain stimulation?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for deep brain stimulation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for deep brain stimulation?
deep brain stimulation research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a deep brain stimulation clinical trial?
Eligibility criteria for deep brain stimulation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Phase 3
1
Top Sponsors
Shanghai Mental Health Center 1 trial
Annovis Bio Inc. 1 trial
University of Florida 1 trial
University of California, San Francisco 1 trial
University of Minnesota 1 trial

Recruiting Clinical Trials

NCT06112067
Recruiting
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
Enrollment
18 pts
Location
China
Sponsor
Shanghai Mental Health Center
View Trial →
NCT07284784 Phase 2, Phase 3
Recruiting
A Study of Buntanetap in Participants With PD
Enrollment
500 pts
Location
United States
Sponsor
Annovis Bio Inc.
View Trial →
NCT07410598
Recruiting
Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
Enrollment
60 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05065151
Recruiting
Understanding Motivation in Parkinson's Patients Through Neurophysiology
Enrollment
70 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT05493722 EARLY_Phase 1
Recruiting
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
Enrollment
20 pts
Location
United States
Sponsor
University of Minnesota
View Trial →

Related Conditions

parkinson disease (2) parkinson s disease pd (1) motivation (1) refractory epilepsy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology